Suppr超能文献

大鼠心肌梗死中转化酶抑制的激素和心脏效应

Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction.

作者信息

Michel J B, Lattion A L, Salzmann J L, Cerol M L, Philippe M, Camilleri J P, Corvol P

机构信息

INSERM U36, Hôpital Broussais, Paris, France.

出版信息

Circ Res. 1988 Apr;62(4):641-50. doi: 10.1161/01.res.62.4.641.

Abstract

To explain how converting enzyme inhibition could improve the prognosis in cardiac insufficiency, the effect of converting enzyme inhibition (CEI) by S9490-3 (Perindopril) treatment for 2 months (treated infarctions, n = 18) on hormonal plasma variables and the quantitative and qualitative changes in myocardium were studied in an experimental model of left ventricular infarction in rats (untreated infarctions, n = 18) and compared to a sham-operated control group (n = 15). Induction of myocardial infarction was associated with a transient decrease in blood pressure. CEI treatment maintained a lower blood pressure throughout the experimental period. Plasma renin concentration was not significantly increased in the untreated infarct group (155.4 +/- 136.7 ng AI/ml/hr) as compared to the sham-operated group (47.6 +/- 15.9 ng AI/ml/hr). Plasma aldosterone did not change in the three experimental groups. The plasma level of immunoreactive atrial natriuretic factor increased in the untreated infarct group (185 +/- 245 pg/ml) as compared with the control group (76 +/- 40 pg/ml) and was normalized by CEI (66 +/- 60 pg/ml). Body weight was slightly decreased in both treated and untreated infarct groups, whereas the heart weight was significantly increased in the untreated group (1,540 +/- 310 mg) and normalized by treatment (1,145 +/- 180 mg) as compared with sham-operated controls (1,071 +/- 80 mg). The combined atria and right ventricular mass was significantly increased in the untreated infarct group (660 +/- 210 mg) and decreased by treatment (443 +/- 106 mg) but was not completely normalized (controls, 343 +/- 40 mg). Left ventricular isomyosin profiles were modified by myocardial infarction as compared with controls: V1 form decreased from 62.4 +/- 9.4% in the sham-operated group to 41.6 +/- 13.4% in the infarct group, and the V3 form increased from 13.0 +/- 4.7% in sham-operated animals to 27.4 +/- 11.8% in untreated infarct animals. CEI treatment partially, but significantly, reversed this modification of the isomyosin profile (V1, 53.0 +/- 14.4%; V3, 17.5 +/- 8.0%). Volume density of collagen was significantly increased in the untreated infarct rats (4.14 +/- 0.81% versus 2.68 +/- 0.49% in controls), and this was reversed by treatment (2.95 +/- 0.66%). Messenger RNA encoding for atrial natriuretic factor, measured by dot blot hybridization, was significantly increased in both the atria and the ventricles in the untreated infarct group, and treatment by CEI partially reversed this increase. Thus, myocardial infarction profoundly modified several variables of peripheral circulation and quantitative and qualitative myocardial protein expression.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

为了解释转换酶抑制如何改善心功能不全的预后,在大鼠左心室梗死实验模型中(未治疗梗死组,n = 18)研究了用S9490 - 3(培哚普利)进行2个月转换酶抑制(CEI)治疗(治疗梗死组,n = 18)对血浆激素变量以及心肌定量和定性变化的影响,并与假手术对照组(n = 15)进行比较。心肌梗死的诱导与血压短暂下降有关。CEI治疗在整个实验期间维持较低血压。与假手术组(47.6±15.9 ng AI/ml/hr)相比,未治疗梗死组(155.4±136.7 ng AI/ml/hr)血浆肾素浓度未显著升高。三个实验组中血浆醛固酮均未改变。与对照组(76±40 pg/ml)相比,未治疗梗死组血浆免疫反应性心钠素水平升高(185±245 pg/ml),而CEI治疗使其恢复正常(66±60 pg/ml)。治疗和未治疗梗死组体重均略有下降,而与假手术对照组(1071±80 mg)相比,未治疗组心脏重量显著增加(1540±310 mg),治疗后恢复正常(1145±180 mg)。未治疗梗死组心房和右心室联合质量显著增加(660±210 mg),治疗后降低(443±106 mg),但未完全恢复正常(对照组,343±40 mg)。与对照组相比,心肌梗死改变了左心室同工肌球蛋白谱:V1型在假手术组中占62.4±9.4%,在梗死组中降至41.6±13.4%,V3型在假手术动物中占13.0±4.7%,在未治疗梗死动物中升至27.4±11.8%。CEI治疗部分但显著地逆转了同工肌球蛋白谱的这种改变(V1,53.0±14.4%;V3,17.5±8.0%)。未治疗梗死大鼠中胶原的体积密度显著增加(4.14±0.81%,对照组为2.68±0.49%),治疗后逆转(2.95±0.66%)。通过斑点印迹杂交法检测,未治疗梗死组心房和心室中编码心钠素的信使核糖核酸均显著增加,CEI治疗部分逆转了这种增加。因此,心肌梗死深刻改变了外周循环的几个变量以及心肌蛋白质表达的定量和定性情况。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验